These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

717 related items for PubMed ID: 10815938

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Treatment with low-dose interferon-alpha restores the balance between matrix metalloproteinase-9 and E-cadherin expression in human transitional cell carcinoma of the bladder.
    Slaton JW, Karashima T, Perrotte P, Inoue K, Kim SJ, Izawa J, Kedar D, McConkey DJ, Millikan R, Sweeney P, Yoshikawa C, Shuin T, Dinney CP.
    Clin Cancer Res; 2001 Sep; 7(9):2840-53. PubMed ID: 11555602
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Interleukin 10 suppresses tumor growth and metastasis of human melanoma cells: potential inhibition of angiogenesis.
    Huang S, Xie K, Bucana CD, Ullrich SE, Bar-Eli M.
    Clin Cancer Res; 1996 Dec; 2(12):1969-79. PubMed ID: 9816156
    [Abstract] [Full Text] [Related]

  • 6. Bombesin stimulates nuclear factor kappa B activation and expression of proangiogenic factors in prostate cancer cells.
    Levine L, Lucci JA, Pazdrak B, Cheng JZ, Guo YS, Townsend CM, Hellmich MR.
    Cancer Res; 2003 Jul 01; 63(13):3495-502. PubMed ID: 12839933
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Inhibition of tumorigenicity and metastasis of human bladder cancer growing in athymic mice by interferon-beta gene therapy results partially from various antiangiogenic effects including endothelial cell apoptosis.
    Izawa JI, Sweeney P, Perrotte P, Kedar D, Dong Z, Slaton JW, Karashima T, Inoue K, Benedict WF, Dinney CP.
    Clin Cancer Res; 2002 Apr 01; 8(4):1258-70. PubMed ID: 11948141
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Gene expression of angiogenic factors correlates with metastatic potential of prostate cancer cells.
    Aalinkeel R, Nair MP, Sufrin G, Mahajan SD, Chadha KC, Chawda RP, Schwartz SA.
    Cancer Res; 2004 Aug 01; 64(15):5311-21. PubMed ID: 15289337
    [Abstract] [Full Text] [Related]

  • 13. Blockade of NF-kappaB activity in human prostate cancer cells is associated with suppression of angiogenesis, invasion, and metastasis.
    Huang S, Pettaway CA, Uehara H, Bucana CD, Fidler IJ.
    Oncogene; 2001 Jul 12; 20(31):4188-97. PubMed ID: 11464285
    [Abstract] [Full Text] [Related]

  • 14. Androgen deprivation induces selective outgrowth of aggressive hormone-refractory prostate cancer clones expressing distinct cellular and molecular properties not present in parental androgen-dependent cancer cells.
    Tso CL, McBride WH, Sun J, Patel B, Tsui KH, Paik SH, Gitlitz B, Caliliw R, van Ophoven A, Wu L, deKernion J, Belldegrun A.
    Cancer J; 2000 Jul 12; 6(4):220-33. PubMed ID: 11038142
    [Abstract] [Full Text] [Related]

  • 15. A novel antisense inhibitor of MMP-9 attenuates angiogenesis, human prostate cancer cell invasion and tumorigenicity.
    London CA, Sekhon HS, Arora V, Stein DA, Iversen PL, Devi GR.
    Cancer Gene Ther; 2003 Nov 12; 10(11):823-32. PubMed ID: 14605668
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. CL1-GFP: an androgen independent metastatic tumor model for prostate cancer.
    Patel BJ, Pantuck AJ, Zisman A, Tsui KH, Paik SH, Caliliw R, Sheriff S, Wu L, deKernion JB, Tso CL, Belldegrun AS.
    J Urol; 2000 Oct 12; 164(4):1420-5. PubMed ID: 10992426
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Blockade of the type I IGF receptor expression in human prostate cancer cells inhibits proliferation and invasion, up-regulates IGF binding protein-3, and suppresses MMP-2 expression.
    Grzmil M, Hemmerlein B, Thelen P, Schweyer S, Burfeind P.
    J Pathol; 2004 Jan 12; 202(1):50-9. PubMed ID: 14694521
    [Abstract] [Full Text] [Related]

  • 20. Cyclooxygenase-2 promotes prostate cancer progression.
    Fujita H, Koshida K, Keller ET, Takahashi Y, Yoshimito T, Namiki M, Mizokami A.
    Prostate; 2002 Nov 01; 53(3):232-40. PubMed ID: 12386924
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 36.